onr:"swepub:oai:DiVA.org:uu-501510"
Search: onr:"swepub:oai:DiVA.org:uu-501510" > Integrated multi-om...
- 1 of 1
- Previous record
- Next record
- To hitlist
- Österroos, AlbinUppsala universitet,Hematologi (author)
Integrated multi-omic profiling of azacitidine-venetoclax in AML reveals additional targetable pathways to improve the treatment
- BookEnglish
Publisher, publication year, extent ...
- printrdacarrier
Numbers
- LIBRIS-ID:oai:DiVA.org:uu-501510
- https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-501510URI
Supplementary language notes
- Language:English
- Summary in:English
Part of subdatabase
- SwePubSwePub
Classification
Notes
- The combination of venetoclax and azacitidine constitutes the first-line option for patients with acute myeloid leukemia (AML) who are ineligible for intensive chemotherapy. Azacitidine-venetoclax has shown pronounced clinical and preclinical ecacy but the molecular mechanisms causing this synergy remain to be clarified. We applied an integrative multi-omic approach with focus in epigenetics on two AML cell lines to characterize the effects of azacitidine-venetoclax in vitro on chromatin accessibility, DNA methylation and gene expression patterns.We report distinct epigenetic and transcriptomic eects when combining azacitidine and venetoclax as compared to either substance alone. With the application of ATAC-seq, we delineate combination-unique gained pathways including the activation of mRNA splicing and NOTCH-HSF1 signaling but also more widespread heterochromatin compared to azacitidine or venetoclax alone. When assessing methylation status, we observed combination-unique hypermethylation of Rac1- and Rho-associated signaling. We integrate the epigenetic alterations of azacitidine-venetoclax with RNA-seq data and report activation of genes involved in the serine synthesis pathway and NTRK signaling that represent potentially upregulated survival pathways upon azacitidine-venetoclax exposure.We also propose potential synergistic triplet therapies based on in silico drug predictions using condition-wise weighted co-expression networks including inhibitors of proteaseomes, MCL-1 and histone deacetylase. Future studies are needed to investigate whether the inhibition of the mentioned pro-survival pathways or proposed triplets may enhance the effects of azacitidine-venetoclax in AML.
Subject headings and genre
- MEDICIN OCH HÄLSOVETENSKAP Klinisk medicin Hematologi hsv//swe
- MEDICAL AND HEALTH SCIENCES Clinical Medicine Hematology hsv//eng
- Azacitidine
- Venetoclax
- Acute myeloid leukemia
- ATAC-seq
- RNA-seq
- Methylation
- Multi-omics
- In silico drug predictions
- Medicinsk vetenskap
- Medical Science
Added entries (persons, corporate bodies, meetings, titles ...)
- Zhong, Xiangfu (author)
- Gamboa Cedeno, AngelicaUppsala universitet,Hematologi(Swepub:uu)angga698 (author)
- Junkunlo, KingkamonUppsala universitet,Hematologi(Swepub:uu)kinju245 (author)
- Bengtzén, Sofia (author)
- Eriksson, Anna,1977-Uppsala universitet,Hematologi(Swepub:uu)anner268 (author)
- Lehmann, SörenUppsala universitet,Hematologi,Center for Hematology and Regenerative Medicine, Department of Medicine, Huddinge, Sweden(Swepub:uu)sorle534 (author)
- Uppsala universitetHematologi (creator_code:org_t)
Internet link
To the university's database
- 1 of 1
- Previous record
- Next record
- To hitlist
Find more in SwePub
- By the author/editor
- Österroos, Albin
- Zhong, Xiangfu
- Gamboa Cedeno, A ...
- Junkunlo, Kingka ...
- Bengtzén, Sofia
- Eriksson, Anna, ...
- show more...
- Lehmann, Sören
- show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
- MEDICAL AND HEAL ...
- and Clinical Medicin ...
- and Hematology
- By the university
- Uppsala University
Search outside SwePub
- Extend your search to:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - National Library Systems
- LIBRIS.kb.se
